LLY
Eli Lilly and Company
NYSE: LLY · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$934.60
+9.80% today
Updated 2026-04-29
Market cap
$760.43B
P/E ratio
37.03
P/S ratio
11.67x
EPS (TTM)
$22.99
Dividend yield
0.69%
52W range
$620 – $1,132
Volume
2.9M
Eli Lilly and Company (LLY) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.98B | $5.15B | $7.30B | $4.34B | $6.86B | $7.23B | $5.30B | $5.74B | $4.46B | $2.96B | $4.85B | $5.62B | $5.52B | $4.84B | $6.50B | $7.26B | $7.08B | $4.24B | $8.82B | $16.81B |
| Capital expenditures | $1.08B | $1.08B | $947.20M | $855.00M | $1.19B | $1.69B | $1.04B | $1.09B | $1.57B | $1.63B | $1.09B | $2.16B | $3.02B | $1.35B | $2.03B | $1.87B | $2.48B | $7.39B | $8.40B | $7.84B |
| Depreciation | $801.80M | $1.05B | $1.12B | $1.30B | $1.33B | $1.37B | $1.46B | $1.45B | $1.38B | $1.43B | $1.50B | $1.57B | $1.61B | $1.23B | $1.32B | $1.55B | $1.52B | $1.53B | $1.77B | $2.00B |
| Stock-based comp | $359.30M | $282.00M | $255.30M | $368.50M | $231.00M | $147.40M | $141.50M | $144.90M | $156.00M | $217.80M | $255.30M | $281.30M | $279.50M | $312.40M | $308.10M | $342.80M | $371.10M | $628.50M | $645.60M | $626.00M |
| Free cash flow | $2.90B | $4.07B | $6.35B | $3.48B | $5.67B | $5.54B | $4.26B | $4.64B | $2.89B | $1.34B | $3.76B | $3.45B | $2.51B | $3.48B | $4.47B | $5.39B | $4.60B | $-3.15B | $414.30M | $8.97B |
| Investing cash flow | $608.40M | $-4.33B | $-7.27B | $142.80M | $-3.16B | $-4.82B | $-2.83B | $-2.07B | $-3.91B | $26.80M | $-3.14B | $-3.78B | $1.91B | $-8.08B | $-2.26B | $-2.87B | $-3.76B | $-7.15B | $-9.30B | $-10.97B |
| Financing cash flow | $-4.58B | $-844.90M | $2.35B | $-5.53B | $-2.02B | $-2.37B | $-4.42B | $-3.83B | $-166.40M | $-2.92B | $-559.80M | $142.60M | $-5.90B | $-2.32B | $-3.14B | $-4.13B | $-5.41B | $3.50B | $1.23B | $-2.21B |
| Dividends paid | $1.74B | $1.85B | $2.06B | $2.15B | $2.17B | $2.18B | $2.19B | $2.12B | $2.10B | $2.13B | $2.16B | $2.19B | $2.31B | $2.41B | $2.69B | $3.09B | $3.54B | $4.07B | $4.68B | $5.38B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $1.53B | — | $-1.90B | — | $41.40M | $-205.20M | $915.70M | $1.95B | $1.46B | $-5.66B | — | — | $-1.58B | — | — | — |